BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24152999)

  • 1. A MEN2A family with two asymptomatic carriers affected by unilateral renal agenesis.
    Hibi Y; Ohye T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Kurahashi H; Iwase K
    Endocr J; 2014; 61(1):19-23. PubMed ID: 24152999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple endocrine neoplasia type 2 syndromes may be associated with renal malformations.
    Loré F; Talidis F; Di Cairano G; Renieri A
    J Intern Med; 2001 Jul; 250(1):37-42. PubMed ID: 11454140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.
    Zwolak A; Rudzki G; Świrska J; Dudzińska M; Daniluk J; Tarach J
    Endokrynol Pol; 2015; 66(5):462-8. PubMed ID: 26457501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
    Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
    Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].
    Weng Y; Xue SN; Zhang SL; Cheng H; Yan L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):134-137. PubMed ID: 29397600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 2A: case report.
    Păun DL; Poiană C; Petriş R; Radian S; Miulescu RD; Constantinescu G; Orban C
    Chirurgia (Bucur); 2013; 108(6):900-3. PubMed ID: 24331334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C618R mutation in exon 10 of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung's disease.
    Caron P; Attié T; David D; Amiel J; Brousset F; Roger P; Munnich A; Lyonnet S
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2731-3. PubMed ID: 8675603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and genetic screening of an extended family with MEN2A.
    Algün E; Abaci N; Kösem M; Kotan C; Köseoğlu B; Boztepe H; Sekeroğlu R; Aslan H; Topal C; Ayakta H; Uygan I; Alagöl F; Erginel-Unaltuna N; Aksoy H
    J Endocrinol Invest; 2002; 25(7):603-8. PubMed ID: 12150334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytoma as the first manifestation of MEN2A with RET mutation S891A: report of a case.
    Hibi Y; Ohye T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Uchino S; Kosugi S; Kurahashi H; Iwase K
    Surg Today; 2014 Nov; 44(11):2195-200. PubMed ID: 24449023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
    Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR
    Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
    Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome).
    Oishi S; Sato T; Takiguchi-Shirahama S; Nakamura Y
    Endocr J; 1995 Aug; 42(4):527-36. PubMed ID: 8556060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
    Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Homozygous RET K666N Genotype With an MEN2A Phenotype.
    Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of multiple endocrine neoplasia type 2A (MEN2A) with a mutation in the RET gene].
    Ishizu K; Shiraishi K; Kawamura H; Naito K; Takahashi T; Yoshimura K; Tangoku A; Shirahama S
    Hinyokika Kiyo; 1999 Jun; 45(6):407-10. PubMed ID: 10442282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
    Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
    Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between Hirschsprung's disease and multiple endocrine neoplasia type 2a: a systematic review.
    Coyle D; Friedmacher F; Puri P
    Pediatr Surg Int; 2014 Aug; 30(8):751-6. PubMed ID: 24972642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families.
    Wang YP; Li FP; Wang HH; Fang XD; Zhu ZS; Chen YL; Qi XP
    Endocr Metab Immune Disord Drug Targets; 2022; 22(3):339-347. PubMed ID: 34445950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.